STOCKHOLM, Dec. 8, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi® (lecanemab), has been included in the "Commercial Insurance Innovative Drug List", recently introduced by the National Healthcare Security Administration...
Hence then, the article about leqembi included in china s commercial insurance innovative drug list was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Leqembi included in China's commercial insurance innovative drug list )
Also on site :
- Ukraine-Russia war latest: Zelensky calls Putin a ‘global threat’ after Moscow’s deadliest aerial attack this year
- Invitation to telephone conference concerning Duni AB (publ) interim report 1 January - 31 March 2026
- Inside The ‘Landmark’ Exhibition Showcasing The Story of Black British Music at London’s Brand-New V&A